Daily Mail
UK · 11 mins ago
✦ 78◉ Centre
Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
A clinical study of over 4,400 patients found that chemotherapy provided minimal additional benefit for breast cancer patients whose tumours showed low Prosigna test scores, potentially allowing millions to avoid unnecessary treatment.
Millions of breast cancer patients could be spared chemotherapy thanks to groundbreaking gene test
A study that followed more than 4,400 patients aged 40 and over found chemotherapy had 'little or no additional benefit' to people whose tumours had a low Prosigna test score.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!